These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6148986)

  • 1. Chronic central nicotinic blockade after a single administration of the bisquaternary ganglion-blocking drug chlorisondamine.
    Clarke PB
    Br J Pharmacol; 1984 Oct; 83(2):527-35. PubMed ID: 6148986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.
    Clarke PB; Chaudieu I; el-Bizri H; Boksa P; Quik M; Esplin BA; Capek R
    Br J Pharmacol; 1994 Feb; 111(2):397-405. PubMed ID: 7911713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (-)-nicotine.
    Reavill C; Stolerman IP; Kumar R; Garcha HS
    Neuropharmacology; 1986 Sep; 25(9):1067-9. PubMed ID: 3774129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of central nicotinic cholinergic receptor blockade produced by chlorisondamine on learning and memory performance in rats.
    Decker MW; Majchrzak MJ
    Behav Neural Biol; 1993 Sep; 60(2):163-71. PubMed ID: 8117240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the locomotor stimulant action of nicotine in tolerant rats.
    Clarke PB; Kumar R
    Br J Pharmacol; 1983 Nov; 80(3):587-94. PubMed ID: 6640208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine cue in rats: effects of central administration of ganglion-blocking drugs.
    Kumar R; Reavill C; Stolerman IP
    Br J Pharmacol; 1987 Jan; 90(1):239-46. PubMed ID: 2880625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Nov; 113(3):917-25. PubMed ID: 7858886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Feb; 111(2):414-8. PubMed ID: 8004385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.
    Clarke PB; Kumar R
    Br J Pharmacol; 1983 Feb; 78(2):329-37. PubMed ID: 6131718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of nicotine on the acquisition of an autoshaped lever-touch response in rats.
    Mundy WR; Iwamoto ET
    Psychopharmacology (Berl); 1988; 94(2):267-74. PubMed ID: 3127855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological actions of nicotine on substantia nigra single units.
    Clarke PB; Hommer DW; Pert A; Skirboll LR
    Br J Pharmacol; 1985 Aug; 85(4):827-35. PubMed ID: 4041681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorisondamine inhibits the nicotine-induced stimulation of c-fos in the pigeon brain for up to 2 weeks.
    Chadman KK; Woods JH; Stitzel J
    Nicotine Tob Res; 2007 Sep; 9(9):927-36. PubMed ID: 17763108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon.
    Chadman KK; Woods JH
    J Pharmacol Exp Ther; 2004 Jan; 308(1):73-8. PubMed ID: 14566012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraneuronal accumulation and persistence of radiolabel in rat brain following in vivo administration of [3H]-chlorisondamine.
    el-Bizri H; Rigdon MG; Clarke PB
    Br J Pharmacol; 1995 Nov; 116(5):2503-9. PubMed ID: 8581291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats.
    Marenco T; Bernstein S; Cumming P; Clarke PB
    Br J Pharmacol; 2000 Jan; 129(1):147-55. PubMed ID: 10694214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the reward-potentiating effects of nicotine on lateral hypothalamic brain stimulation by chlorisondamine.
    Wise R; Marcangione C; Bauco P
    Synapse; 1998 May; 29(1):72-9. PubMed ID: 9552176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ganglion blocking agents on nicotine extensor convulsions and lethality in mice.
    Aceto MD; Bentley HC; Dembinski JR
    Br J Pharmacol; 1969 Sep; 37(1):104-11. PubMed ID: 4390479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some effects of nicotine on food and water intake in undeprived rats.
    Clarke PB; Kumar R
    Br J Pharmacol; 1984 May; 82(1):233-9. PubMed ID: 6539631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
    Reuben M; Louis M; Clarke PB
    Br J Pharmacol; 1998 Nov; 125(6):1218-27. PubMed ID: 9863650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.